Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 06 2020
Historique:
received: 06 12 2019
accepted: 12 02 2020
pubmed: 16 2 2020
medline: 30 1 2021
entrez: 16 2 2020
Statut: ppublish

Résumé

Congenital pituitary hormone deficiencies with syndromic phenotypes and/or familial occurrence suggest genetic hypopituitarism; however, in many such patients the underlying molecular basis of the disease remains unknown. To describe patients with syndromic hypopituitarism due to biallelic loss-of-function variants in TBC1D32, a gene implicated in Sonic Hedgehog (Shh) signaling. Referral center. A Finnish family of 2 siblings with panhypopituitarism, absent anterior pituitary, and mild craniofacial dysmorphism, and a Pakistani family with a proband with growth hormone deficiency, anterior pituitary hypoplasia, and developmental delay. The patients were investigated by whole genome sequencing. Expression profiling of TBC1D32 in human fetal brain was performed through in situ hybridization. Stable and dynamic protein-protein interaction partners of TBC1D32 were investigated in HEK cells followed by mass spectrometry analyses. Genetic and phenotypic features of patients with biallelic loss-of-function mutations in TBC1D32. The Finnish patients harboured compound heterozygous loss-of-function variants (c.1165_1166dup p.(Gln390Phefs*32) and c.2151del p.(Lys717Asnfs*29)) in TBC1D32; the Pakistani proband carried a known pathogenic homozygous TBC1D32 splice-site variant c.1372 + 1G > A p.(Arg411_Gly458del), as did a fetus with a cleft lip and partial intestinal malrotation from a terminated pregnancy within the same pedigree. TBC1D32 was expressed in the developing hypothalamus, Rathke's pouch, and areas of the hindbrain. TBC1D32 interacted with proteins implicated in cilium assembly, Shh signaling, and brain development. Biallelic TBC1D32 variants underlie syndromic hypopituitarism, and the underlying mechanism may be via disrupted Shh signaling.

Identifiants

pubmed: 32060556
pii: 5736371
doi: 10.1210/clinem/dgaa078
pmc: PMC7138537
pii:
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Biomarkers 0
TBC1D32 protein, human 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-099-0002-RG-UCLIC
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom

Informations de copyright

© Endocrine Society 2020.

Références

Hum Mol Genet. 2016 Feb 15;25(4):693-705
pubmed: 26685159
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13424-9
pubmed: 14581620
Dev Biol. 2008 Sep 1;321(1):27-39
pubmed: 18590716
Clin Endocrinol (Oxf). 2015 May;82(5):728-38
pubmed: 25327282
Nat Methods. 2013 Apr;10(4):307-14
pubmed: 23455922
Nat Commun. 2016 May 13;7:11491
pubmed: 27173435
Development. 2004 May;131(9):2149-59
pubmed: 15105374
J Med Genet. 2017 Jun;54(6):371-380
pubmed: 28289185
J Biol Chem. 2014 Sep 12;289(37):25639-54
pubmed: 25077969
Brain Plast. 2018 Aug 10;3(2):119-128
pubmed: 30151337
Dev Biol. 2018 Feb 1;434(1):24-35
pubmed: 29166577
Hum Mutat. 2014 Jan;35(1):36-40
pubmed: 24285566
Annu Rev Cell Dev Biol. 2007;23:345-73
pubmed: 17506691
Dev Cell. 2010 Feb 16;18(2):237-47
pubmed: 20159594
Biomed Res Int. 2016;2016:7532714
pubmed: 27066502
Handb Clin Neurol. 2014;124:3-15
pubmed: 25248576
J Clin Endocrinol Metab. 2020 Jun 1;105(6):
pubmed: 32060556
J Clin Endocrinol Metab. 2015 Apr;100(4):1221-4
pubmed: 25664603
Endocr Rev. 2016 Dec;37(6):636-675
pubmed: 27828722
Curr Biol. 2012 Mar 6;22(5):414-9
pubmed: 22326026
PLoS Biol. 2019 Jul 17;17(7):e3000381
pubmed: 31314751
PLoS Genet. 2017 Aug 17;13(8):e1006912
pubmed: 28817564
J Endocrinol. 2012 Nov;215(2):239-45
pubmed: 22872762
Hum Mutat. 2017 Mar;38(3):269-274
pubmed: 28054750
Curr Opin Genet Dev. 2013 Aug;23(4):429-37
pubmed: 23725801
Cell Syst. 2017 Apr 26;4(4):430-444.e5
pubmed: 28330616
Eur J Endocrinol. 2016 Jun;174(6):R239-47
pubmed: 26733480
Endocr Rev. 2009 Dec;30(7):790-829
pubmed: 19837867
Nat Rev Mol Cell Biol. 2017 Sep;18(9):533-547
pubmed: 28698599
Genome Biol. 2007;8(9):R183
pubmed: 17784955
Development. 2006 Jun;133(12):2395-405
pubmed: 16687448
Curr Opin Cell Biol. 2010 Aug;22(4):461-70
pubmed: 20466531
Nat Commun. 2018 Mar 22;9(1):1188
pubmed: 29568061
Dev Biol. 2010 Dec 15;348(2):199-209
pubmed: 20934421

Auteurs

Johanna Hietamäki (J)

Pediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.

Louise C Gregory (LC)

Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, UK.

Sandy Ayoub (S)

North West Thames Regional Genetic Service, London North West University Healthcare NHS Trust, Harrow, UK.

Anna-Pauliina Iivonen (AP)

Department of Physiology, Medicum Unit, and Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Kirsi Vaaralahti (K)

Department of Physiology, Medicum Unit, and Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Xiaonan Liu (X)

Institute of Biotechnology & HiLIFE, University of Helsinki, Helsinki, Finland.

Nina Brandstack (N)

Department of Radiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Andrew J Buckton (AJ)

London North Genomic Laboratory Hub, Great Ormond Street Hospital NHS Trust, London, UK.

Tiina Laine (T)

Pediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.

Johanna Känsäkoski (J)

Department of Physiology, Medicum Unit, and Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Matti Hero (M)

Pediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.

Päivi J Miettinen (PJ)

Pediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.

Markku Varjosalo (M)

Institute of Biotechnology & HiLIFE, University of Helsinki, Helsinki, Finland.

Emma Wakeling (E)

North West Thames Regional Genetic Service, London North West University Healthcare NHS Trust, Harrow, UK.

Mehul T Dattani (MT)

Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, UK.
Molecular Basis of Rare Diseases Section, Genetics and Genomic Medicine Programme, UCL Great Ormond Street Institute of Child Health, London, UK.
Department of Endocrinology, Great Ormond Street Hospital for Children, London, UK.

Taneli Raivio (T)

Pediatric Research Center, Helsinki University Hospital, New Children's Hospital, Pediatric Research Center, Helsinki, Finland.
Department of Physiology, Medicum Unit, and Translational Stem Cell Biology and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH